Pharmaceutical

Cosmos Health’s Cana Secures Contract Manufacturing Agreement with Australia’s Humacology for up to 500,000 CBD Units Annually

CHICAGO, IL / ACCESSWIRE / July 9, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 year ago

Clinion Applauded by Frost & Sullivan for Enabling Interoperability and Continuity in Clinical Trials Management with its eClinical Solutions

Clinion's decentralized clinical trials and innovative eClinical platform enhance accessibility, cost efficiency, ease of use, regulatory compliance, and sustainability in…

1 year ago

Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access

One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new…

1 year ago

IntegriChain Acquires Federal Compliance Solutions, Creating Pharma’s Deepest Contracts & Pricing and Gross-to-Net Advisory and Outsourcing Team

Combined entity bolsters expertise to help Pharma optimize commercial performance in the face of mounting regulatory and commercial pressures on net…

1 year ago

New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution

Presented at Respiratory Drug Delivery 2024, the Nasdepi Canine Study Indicates the Dry Powder Nasal Solution Provides a Faster and…

1 year ago

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

BOULDER, CO / ACCESSWIRE / July 9, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing…

1 year ago

Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets

Leader Healthcare Group is Chosen as Distribution Partner to Launch Zomedica® Products into the Gulf Cooperation Council Countries in the…

1 year ago

Raphael Pharmaceutical Issues Letter to Shareholders

Highlights Company’s exclusive relationship with Rambam Health Care Campus, differentiated cannabinoid-based technology platform, promising lead product candidate for rheumatoid arthritis,…

1 year ago

Sharps Technology CEO Urges Shareholders to Vote in Support of the Three Proposals by the July 12 Voting Deadline

Robert Hayes issues a letter to shareholders asking their voting approval on three proposals vital to the Company’s continued growth.…

1 year ago

Organic & Natural Health Association Welcomes New President and Four New Board Members

Todd Norton Named Board President of O&N Health Todd Norton, the vice president of business development at Aker BioMarine, and…

1 year ago